Junxiu Zhang
Impact in
-
- Thyroid Disorders and Treatments
-
- Advanced Glycation End Products research
Papers in
-
- Retinal Diseases and Treatments 3
- Glaucoma and retinal disorders 2
Junxiu Zhang
25 papers receiving 445 citations
Peers
Comparison fields: 5 of 83
- Endocrinology, Diabetes and Metabolism 112
- Clinical Biochemistry 30
- Cancer Research 57
- Health Informatics 5
- Ophthalmology 29
Countries citing papers authored by Junxiu Zhang
This map shows the geographic impact of Junxiu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxiu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxiu Zhang more than expected).
Fields of papers citing papers by Junxiu Zhang
This network shows the impact of papers produced by Junxiu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxiu Zhang. The network helps show where Junxiu Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Junxiu Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 62 | |
| 6 | 2021 | 23 | |
| 7 | 2021 | 11 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 19 | |
| 10 | 2021 | 6 | |
| 11 | Mast cell activation, TLR4-NF-κB/TNF-α pathway variation in rats' intestinal ischemia-reperfusion injury and Tongxinluo's therapeutic effect. | 2020 | 2 |
| 12 | Preventive effect of Tongxinluo on endothelial survival and vascular integrity, together with inhibition of inflammatory reaction in rats model of intestine ischemia/reperfusion injury. | 2018 | 5 |
| 13 | 2017 | 9 | |
| 14 | The Relationship between the Prices of Shipping Market and China’s Economy | 2017 | 1 |
| 15 | 2017 | 9 | |
| 16 | 2017 | 1 | |
| 17 | 2014 | 30 | |
| 18 | 2013 | 35 | |
| 19 | 2013 | 1 | |
| 20 | 2012 | 21 |
About Junxiu Zhang
Junxiu Zhang is a scholar working on Ophthalmology, Clinical Biochemistry, Cancer Research, Neurology and Endocrinology, Diabetes and Metabolism, having authored 25 papers that have together received 450 indexed citations. Recurring topics across this work include Sesame and Sesamin Research (5 papers), Retinal Diseases and Treatments (3 papers), MicroRNA in disease regulation (3 papers), Lipid metabolism and disorders (3 papers), Thyroid Disorders and Treatments (3 papers), Neurological Disease Mechanisms and Treatments (2 papers), Congenital heart defects research (2 papers) and Glaucoma and retinal disorders (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (112 citations), Clinical Biochemistry (30 citations), Cancer Research (57 citations), Health Informatics (5 citations) and Ophthalmology (29 citations). Junxiu Zhang has collaborated with scholars based in China and United States. Frequent co-authors include Yang Jie-ren, Xiang Kong, Zhi Zheng, Yuanyuan Gong, Zijia Liu, Wenxing Li, Liqun Guo, Mingzhe Ma, Qing Su and Guodong Wang. Their work appears in journals such as Human Factors and Ergonomics in Manufacturing & Service Industries, Scientific Reports, Nutrients, Nature Communications and Genetics in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.